UTMD Utah Medical Products, Inc.
$73.06▼ -0.63%
Healthcare
Other
After hours
$73.06▲ +0.00%
Oct 27, 4:00 PM ET
Volume 45.0K
Avg Volume (10D) 38.5K
Key Metrics & Fundamentals
Market Cap
$231.97M
P/E Ratio
21.9
Div Yield
1.69%
52W Range
53.66 - 76.89
% vs 50 MA
-0.10%
% vs 200 MA
7.54%
RSI-14
43.4
MACD Histogram
-0.2400
Beta (1Y vs SPY)
0.24
Free Cash Flow
$1.25M
Gross Rev
$8.53M
Gross Profit
$4.76M
EBITDA
$2.89M
COGS
$3.77M
Operating Exp
$2.11M
Operating Income
$2.65M
EBIT
$2.65M
Pretax Income
$3.29M
Net Income
$2.69M
EPS (Diluted)
0.84
Price & Volume History
Loading chart…
Recent News
Utah Medical Products (UTMD) Q3 Results Highlight Revenue Pressure Beneath Strong Margins
Simply Wall St. · Oct 24, 2026 2:08 PM ET
Utah Medical: Q3 Earnings Snapshot
Associated Press · Oct 22, 2026 9:18 AM ET
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2026
ACCESS Newswire · Oct 22, 2026 9:00 AM ET
UTMD Trades at a Premium to the Industry: How to Play the Stock?
Zacks · Oct 8, 2026 1:02 PM ET
Utah Medical Products, Inc. Extends Tender Offer
ACCESS Newswire · Oct 5, 2026 8:30 AM ET
Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date
ACCESS Newswire · Sep 25, 2026 11:00 AM ET
Utah Medical Launches Tender Offer
MT Newswires · Sep 24, 2026 5:02 PM ET
Utah Medical Products, Inc. Commences Tender Offer
ACCESS Newswire · Sep 24, 2026 4:45 PM ET
Utah Medical Products Inc's Dividend Analysis
GuruFocus.com · Sep 17, 2026 7:09 AM ET
UTMD Announces Self-Tender for 20% of Its Shares
ACCESS Newswire · Sep 15, 2026 10:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See UTMD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.